Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA)

Author:

,Evans R P T,Kamarajah S K,Nepogodiev D,Bundred J,Hodson J,Blanco-Colino R,Kidane B,Kauppilla J,Wallner B,van Hillegersberg R,Gossage J,Wijnhoven B,Vohra R,Singh P,Griffiths E A,Hodson J,Kamarajah S K,Griffiths E A,Alderson D,Bundred J,Evans R P T,Gossage J,Griffiths E A,Jefferies B,Kamarajah S K,McKay S,Mohamed I,Nepogodiev D,Siaw-Acheampong K,Singh P,van Hillegersberg R,Vohra R,Wanigasooriya K,Gjata A,Moreno J I,Takeda F R,Kidane B,Guevara Castro R,Harustiak T,Bekele A,Kechagias A,Gockel I,Kennedy A,Da Roit A,Bagajevas A,Azagra J S,Mahendran H A,Mejía-Fernández L,Wijnhoven B P L,El Kafsi J,Sayyed R H,Sousa M,Sampaio A S,Negoi I,Blanco R,Wallner B,Schneider P M,Hsu P K,Isik A,Gananadha S,Wills V,Devadas M,Duong C,Talbot M,Hii M W,Jacobs R,Andreollo N A,Johnston B,Darling G,Isaza-Restrepo A,Rosero G,Arias-Amézquita F,Raptis D,Gaedcke J,Reim D,Izbicki J,Egberts J H,Dikinis S,Kjaer D W,Larsen M H,Achiam M P,Saarnio J,Theodorou D,Liakakos T,Korkolis D P,Robb W B,Collins C,Murphy T,Reynolds J,Tonini V,Migliore M,Bonavina L,Valmasoni M,Bardini R,Weindelmayer J,Terashima M,White R E,Alghunaim E,Elhadi M,Leon-Takahashi A M,Medina-Franco H,Lau P C,Okonta K E,Heisterkamp J,Rosman C,van Hillegersberg R,Beban G,Babor R,Gordon A,Rossaak J I,Pal K M I,Qureshi A U,Naqi S A,Syed A A,Barbosa J,Vicente C S,Leite J,Freire J,Casaca R,Costa R C T,Scurtu R R,Mogoanta S S,Bolca C,Constantinoiu S,Sekhniaidze D,Bjelović M,So J B Y,Gačevski G,Loureiro C,Pera M,Bianchi A,Moreno Gijón M,Martín Fernández J,Trugeda Carrera M S,Vallve-Bernal M,Cítores Pascual M A,Elmahi S,Hedberg J,Mönig S,Gutknecht S,Tez M,Guner A,Tirnaksiz M B,Colak E,Sevinç B,Hindmarsh A,Khan I,Khoo D,Byrom R,Gokhale J,Wilkerson P,Jain P,Chan D,Robertson K,Iftikhar S,Skipworth R,Forshaw M,Higgs S,Gossage J,Nijjar R,Viswanath Y K S,Turner P,Dexter S,Boddy A,Allum W H,Oglesby S,Cheong E,Beardsmore D,Vohra R,Maynard N,Berrisford R,Mercer S,Puig S,Melhado R,Kelty C,Underwood T,Dawas K,Lewis W,Al-Bahrani A,Bryce G,Thomas M,Arndt A T,Palazzo F,Meguid R A,Fergusson J,Beenen E,Mosse C,Salim J,Cheah S,Wright T,Cerdeira M P,McQuillan P,Richardson M,Liem H,Spillane J,Yacob M,Albadawi F,Thorpe T,Dingle A,Cabalag C,Loi K,Fisher O M,Ward S,Read M,Johnson M,Bassari R,Bui H,Cecconello I,Sallum R A A,da Rocha J R M,Lopes L R,Tercioti V,Coelho J D S,Ferrer J A P,Buduhan G,Tan L,Srinathan S,Shea P,Yeung J,Allison F,Carroll P,Vargas-Barato F,Gonzalez F,Ortega J,Nino-Torres L,Beltrán-García T C,Castilla L,Pineda M,Bastidas A,Gómez-Mayorga J,Cortés N,Cetares C,Caceres S,Duarte S,Pazdro A,Snajdauf M,Faltova H,Sevcikova M,Mortensen P B,Katballe N,Ingemann T,Morten B,Kruhlikava I,Ainswort A P,Stilling N M,Eckardt J,Holm J,Thorsteinsson M,Siemsen M,Brandt B,Nega B,Teferra E,Tizazu A,Kauppila J S,Koivukangas V,Meriläinen S,Gruetzmann R,Krautz C,Weber G,Golcher H,Emons G,Azizian A,Ebeling M,Niebisch S,Kreuser N,Albanese G,Hesse J,Volovnik L,Boecher U,Reeh M,Triantafyllou S,Schizas D,Michalinos A,Mpali E,Mpoura M,Charalabopoulos A,Manatakis D K,Balalis D,Bolger J,Baban C,Mastrosimone A,McAnena O,Quinn A,Súilleabháin C B Ó,Hennessy M M,Ivanovski I,Khizer H,Ravi N,Donlon N,Cervellera M,Vaccari S,Bianchini S,Sartarelli I,Asti E,Bernardi D,Merigliano S,Provenzano L,Scarpa M,Saadeh L,Salmaso B,De Manzoni G,Giacopuzzi S,Mendola R La,De Pasqual C A,Tsubosa Y,Niihara M,Irino T,Makuuchi R,Ishii K,Mwachiro M,Fekadu A,Odera A,Mwachiro E,AlShehab D,Ahmed H A,Shebani A O,Elhadi A,Elnagar F A,Elnagar H F,Makkai-Popa S T,Wong L F,Yunrong T,Thanninalai S,Aik H C,Soon P W,Huei T J,Basave H N L,Cortés-González R,Lagarde S M,van Lanschot J J B,Cords C,Jansen W A,Martijnse I,Matthijsen R,Bouwense S,Klarenbeek B,Verstegen M,van Workum F,Ruurda J P,van der Sluis P C,de Maat M,Evenett N,Johnston P,Patel R,MacCormick A,Young M,Smith B,Ekwunife C,Memon A H,Shaikh K,Wajid A,Khalil N,Haris M,Mirza Z U,Qudus S B A,Sarwar M Z,Shehzadi A,Raza A,Jhanzaib M H,Farmanali J,Zakir Z,Shakeel O,Nasir I,Khattak S,Baig M,Noor M A,Ahmed H H,Naeem A,Pinho A C,da Silva R,Matos H,Braga T,Monteiro C,Ramos P,Cabral F,Gomes M P,Martins P C,Correia A M,Videira J F,Ciuce C,Drasovean R,Apostu R,Ciuce C,Paitici S,Racu A E,Obleaga C V,Beuran M,Stoica B,Ciubotaru C,Negoita V,Cordos I,Birla R D,Predescu D,Hoara P A,Tomsa R,Shneider V,Agasiev M,Ganjara I,Gunjić D,Veselinović M,Babič T,Chin T S,Shabbir A,Kim G,Crnjac A,Samo H,Díez del Val I,Leturio S,Val I Díez del,Leturio S,Ramón J M,Cero M Dal,Rifá S,Rico M,Pagan Pomar A,Martinez Corcoles J A,Rodicio Miravalles J L,Pais S A,Turienzo S A,Alvarez L S,Campos P V,Rendo A G,García S S,Santos E P G,Martínez E T,Fernández Díaz M J,Magadán Álvarez C,Concepción Martín V,Díaz López C,Rosat Rodrigo A,Pérez Sánchez L E,Bailón Cuadrado M,Tinoco Carrasco C,Choolani Bhojwani E,Sánchez D P,Ahmed M E,Dzhendov T,Lindberg F,Rutegård M,Sundbom M,Mickael C,Colucci N,Schnider A,Er S,Kurnaz E,Turkyilmaz S,Turkyilmaz A,Yildirim R,Baki B E,Akkapulu N,Karahan O,Damburaci N,Hardwick R,Safranek P,Sujendran V,Bennett J,Afzal Z,Shrotri M,Chan B,Exarchou K,Gilbert T,Amalesh T,Mukherjee D,Mukherjee S,Wiggins T H,Kennedy R,McCain S,Harris A,Dobson G,Davies N,Wilson I,Mayo D,Bennett D,Young R,Manby P,Blencowe N,Schiller M,Byrne B,Mitton D,Wong V,Elshaer A,Cowen M,Menon V,Tan L C,McLaughlin E,Koshy R,Sharp C,Brewer H,Das N,Cox M,Al Khyatt W,Worku D,Iqbal R,Walls L,McGregor R,Fullarton G,Macdonald A,MacKay C,Craig C,Dwerryhouse S,Hornby S,Jaunoo S,Wadley M,Baker C,Saad M,Kelly M,Davies A,Di Maggio F,McKay S,Mistry P,Singhal R,Tucker O,Kapoulas S,Powell-Brett S,Davis P,Bromley G,Watson L,Verma R,Ward J,Shetty V,Ball C,Pursnani K,Sarela A,Sue Ling H,Mehta S,Hayden J,To N,Palser T,Hunter D,Supramaniam K,Butt Z,Ahmed A,Kumar S,Chaudry A,Moussa O,Kordzadeh A,Lorenzi B,Wilson M,Patil P,Noaman I,Willem J,Bouras G,Evans R,Singh M,Warrilow H,Ahmad A,Tewari N,Yanni F,Couch J,Theophilidou E,Reilly J J,Singh P,van Boxel G,Akbari K,Zanotti D,Sgromo B,Sanders G,Wheatley T,Ariyarathenam A,Reece-Smith A,Humphreys L,Choh C,Carter N,Knight B,Pucher P,Athanasiou A,Mohamed I,Tan B,Abdulrahman M,Vickers J,Akhtar K,Chaparala R,Brown R,Alasmar M M A,Ackroyd R,Patel K,Tamhankar A,Wyman A,Walker R,Grace B,Abbassi N,Slim N,Ioannidi L,Blackshaw G,Havard T,Escofet X,Powell A,Owera A,Rashid F,Jambulingam P,Padickakudi J,Ben-Younes H,Mccormack K,Makey I A,Karush M K,Seder C W,Liptay M J,Chmielewski G,Rosato E L,Berger A C,Zheng R,Okolo E,Singh A,Scott C D,Weyant M J,Mitchell J D

Abstract

Abstract Background The Esophagectomy Complications Consensus Group (ECCG) and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) have set standards in reporting outcomes after oesophagectomy. Reporting outcomes from selected high-volume centres or centralized national cancer programmes may not, however, be reflective of the true global prevalence of complications. This study aimed to compare complication rates after oesophagectomy from these existing sources with those of an unselected international cohort from the Oesophago-Gastric Anastomosis Audit (OGAA). Methods The OGAA was a prospective multicentre cohort study coordinated by the West Midlands Research Collaborative, and included patients undergoing oesophagectomy for oesophageal cancer between April and December 2018, with 90 days of follow-up. Results The OGAA study included 2247 oesophagectomies across 137 hospitals in 41 countries. Comparisons with the ECCG and DUCA found differences in baseline demographics between the three cohorts, including age, ASA grade, and rates of chronic pulmonary disease. The OGAA had the lowest rates of neoadjuvant treatment (OGAA 75.1 per cent, ECCG 78.9 per cent, DUCA 93.5 per cent; P < 0.001). DUCA exhibited the highest rates of minimally invasive surgery (OGAA 57.2 per cent, ECCG 47.9 per cent, DUCA 85.8 per cent; P < 0.001). Overall complication rates were similar in the three cohorts (OGAA 63.6 per cent, ECCG 59.0 per cent, DUCA 62.2 per cent), with no statistically significant difference in Clavien–Dindo grades (P = 0.752). However, a significant difference in 30-day mortality was observed, with DUCA reporting the lowest rate (OGAA 3.2 per cent, ECCG 2.4 per cent, DUCA 1.7 per cent; P = 0.013). Conclusion Despite differences in rates of co-morbidities, oncological treatment strategies, and access to minimal-access surgery, overall complication rates were similar in the three cohorts.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3